165 related articles for article (PubMed ID: 25736752)
41. Chemical Probes for Profiling of MALT1 Protease Activity.
Verhelst SHL; Prothiwa M
Chembiochem; 2023 Nov; 24(21):e202300444. PubMed ID: 37607867
[TBL] [Abstract][Full Text] [Related]
42. BCL10GFP fusion protein as a substrate for analysis of determinants required for mucosa-associated lymphoid tissue 1 (MALT1)-mediated cleavage.
Jou SY; Chang CC; Wu CH; Chen MR; Tsai CH; Chuang WH; Chen YH; Cheng AL; Doong SL
J Biomed Sci; 2012 Oct; 19(1):85. PubMed ID: 23035874
[TBL] [Abstract][Full Text] [Related]
43. MALT1, BCL10 and FOXP1 in salivary gland mucosa-associated lymphoid tissue lymphomas.
Borovecki A; Korac P; Ventura RA; Perisa MM; Banham AH; Dominis M
Pathol Int; 2007 Jan; 57(1):47-51. PubMed ID: 17199743
[TBL] [Abstract][Full Text] [Related]
44. Identification of β-Lapachone Analogs as Novel MALT1 Inhibitors To Treat an Aggressive Subtype of Diffuse Large B-Cell Lymphoma.
Lim SM; Jeong Y; Lee S; Im H; Tae HS; Kim BG; Park HD; Park J; Hong S
J Med Chem; 2015 Nov; 58(21):8491-502. PubMed ID: 26496175
[TBL] [Abstract][Full Text] [Related]
45. The paracaspase MALT1: biological function and potential for therapeutic inhibition.
Jaworski M; Thome M
Cell Mol Life Sci; 2016 Feb; 73(3):459-73. PubMed ID: 26507244
[TBL] [Abstract][Full Text] [Related]
46. MALT1 Protease Activity Is Required for Innate and Adaptive Immune Responses.
Yu JW; Hoffman S; Beal AM; Dykon A; Ringenberg MA; Hughes AC; Dare L; Anderson AD; Finger J; Kasparcova V; Rickard D; Berger SB; Ramanjulu J; Emery JG; Gough PJ; Bertin J; Foley KP
PLoS One; 2015; 10(5):e0127083. PubMed ID: 25965667
[TBL] [Abstract][Full Text] [Related]
47. Protease activity of MALT1: a mystery unravelled.
Kirchhofer D; Vucic D
Biochem J; 2012 Jun; 444(2):e3-5. PubMed ID: 22574776
[TBL] [Abstract][Full Text] [Related]
48. Cleavage by MALT1 induces cytosolic release of A20.
Malinverni C; Unterreiner A; Staal J; Demeyer A; Galaup M; Luyten M; Beyaert R; Bornancin F
Biochem Biophys Res Commun; 2010 Oct; 400(4):543-7. PubMed ID: 20804738
[TBL] [Abstract][Full Text] [Related]
49. Targeting MALT1 for the treatment of diffuse large B-cell lymphoma.
Seshadri MR; Melnick AM
Leuk Lymphoma; 2022 Apr; 63(4):789-798. PubMed ID: 34783281
[TBL] [Abstract][Full Text] [Related]
50. Backbone Assignment of the MALT1 Paracaspase by Solution NMR.
Unnerståle S; Nowakowski M; Baraznenok V; Stenberg G; Lindberg J; Mayzel M; Orekhov V; Agback T
PLoS One; 2016; 11(1):e0146496. PubMed ID: 26788853
[TBL] [Abstract][Full Text] [Related]
51. t(14;18)(q32;q21) involving IGH and MALT1 is uncommon in cutaneous MALT lymphomas and primary cutaneous diffuse large B-cell lymphomas.
Wongchaowart NT; Kim B; Hsi ED; Swerdlow SH; Tubbs RR; Cook JR
J Cutan Pathol; 2006 Apr; 33(4):286-92. PubMed ID: 16630178
[TBL] [Abstract][Full Text] [Related]
52. CARD14-Mediated Activation of Paracaspase MALT1 in Keratinocytes: Implications for Psoriasis.
Van Nuffel E; Schmitt A; Afonina IS; Schulze-Osthoff K; Beyaert R; Hailfinger S
J Invest Dermatol; 2017 Mar; 137(3):569-575. PubMed ID: 27939769
[TBL] [Abstract][Full Text] [Related]
53. Multifunctional roles for MALT1 in T-cell activation.
Thome M
Nat Rev Immunol; 2008 Jul; 8(7):495-500. PubMed ID: 18575460
[TBL] [Abstract][Full Text] [Related]
54. Successful clinical treatment and functional immunological normalization of human MALT1 deficiency following hematopoietic stem cell transplantation.
Rozmus J; McDonald R; Fung SY; Del Bel KL; Roden J; Senger C; Schultz KR; McKinnon ML; Davis J; Turvey SE
Clin Immunol; 2016 Jul; 168():1-5. PubMed ID: 27109639
[TBL] [Abstract][Full Text] [Related]
55. Crystal structure of the mucosa-associated lymphoid tissue lymphoma translocation 1 (MALT1) paracaspase region.
Yu JW; Jeffrey PD; Ha JY; Yang X; Shi Y
Proc Natl Acad Sci U S A; 2011 Dec; 108(52):21004-9. PubMed ID: 22158899
[TBL] [Abstract][Full Text] [Related]
56. Targeting B-cell lymphomas with inhibitors of the MALT1 paracaspase.
Hailfinger S; Lenz G; Thome M
Curr Opin Chem Biol; 2014 Dec; 23():47-55. PubMed ID: 25285878
[TBL] [Abstract][Full Text] [Related]
57. Anti-apoptotic action of API2-MALT1 fusion protein involved in t(11;18)(q21;q21) MALT lymphoma.
Hosokawa Y
Apoptosis; 2005 Jan; 10(1):25-34. PubMed ID: 15711920
[TBL] [Abstract][Full Text] [Related]
58. Malt1 and cIAP2-Malt1 as effectors of NF-kappaB activation: kissing cousins or distant relatives?
Kingeter LM; Schaefer BC
Cell Signal; 2010 Jan; 22(1):9-22. PubMed ID: 19772915
[TBL] [Abstract][Full Text] [Related]
59. Development of new Malt1 inhibitors and probes.
Xin BT; Schimmack G; Du Y; Florea BI; van der Marel GA; Driessen C; Krappmann D; Overkleeft HS
Bioorg Med Chem; 2016 Aug; 24(15):3312-29. PubMed ID: 27085674
[TBL] [Abstract][Full Text] [Related]
60. Malt1 self-cleavage is critical for regulatory T cell homeostasis and anti-tumor immunity in mice.
Baens M; Stirparo R; Lampi Y; Verbeke D; Vandepoel R; Cools J; Marynen P; de Bock CE; Bornschein S
Eur J Immunol; 2018 Oct; 48(10):1728-1738. PubMed ID: 30025160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
